Dosing Flexibility Study of Oral Testosterone Undecanoate (TU, LPCN 1021)
NCT03242408
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypogonadism, Male
Interventions
DRUG:
LPCN 1021
Sponsor
Lipocine Inc.